References
- Patel SS, Kimmel PL, Singh A. New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI. Semin Nephrol. 2002; 22:449-58.10.1053/snep.2002.35973
- Hewitson TD. Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol. 2009; 296:F1239-44.1914469110.1152/ajprenal.90521.2008
- Zandi-Nejad K, Eddy AA, Glassock RJ, Brenner BM. Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int Suppl. 2004; 92:S76-89.
- Brock G, Castellanos-Rizaldos E, Hu L, Coticchia C, Skog J. Liquid biopsy for cancer screening, patient stratification and monitoring. Translational Cancer Research. 2015; 4:280-90.
- Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Nat Acad Sci USA. 2004; 101:13368-73.10.1073/pnas.0403453101
- Zhou H, Cheruvanky A, Hu X, Matsumoto T, Hiramatsu N, Cho ME, et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int. 2008; 74:613-21.10.1038/ki.2008.20618509321
- Lv LL, Cao YH, Ni HF, Xu M, Liu D, Liu H, et al. MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. Am J Physiol Renal Physiol. 2013; 305:F1220-7.2394628610.1152/ajprenal.00148.2013
- Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, et al. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol. 2009; 296:F213-29.10.1152/ajprenal.90421.200818784259
- Doi K, Leelahavanichkul A, Hu X, Sidransky KL, Zhou H, Qin Y, et al. Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome. Kidney Int. 2008; 74:1017-25.1863334010.1038/ki.2008.346
- Doi K, Okamoto K, Negishi K, Suzuki Y, Nakao A, Fujita T, et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol. 2006; 168: 1413-24.10.2353/ajpath.2006.05063416651609
- Taylor DM, Threlfall G, Buck AT. Stimulation of renal growth in the rat by folic acid. Nature. 1966; 212: 472-4.10.1038/212472a05970177
- Byrnes KA, Ghidoni JJ, Mayfield ED. Response of the rat kidney to folic acid administration. I. Biochemical studies. Lab Invest. 1972; 26:184-90.
- Byrnes KA, Ghidoni JJ, Suzuki M, Thomas H, Mayfield ED. Response of the rat kidney to folic acid administration. II. Morphologic studies. Lab Invest. 1972; 26:191-200.
- Klingler EL, Evan AP, Anderson RE. Folic acid-induced renal injury and repair. Correlation of structural and functional abnormalities. Arch Pathol Lab Med. 1980; 104:87-93.6892555
- Fink M, Henry M, Tange JD. Experimental folic acid nephropathy. Pathology. 1987; 19:143-9.10.3109/003130287090771252840627
- Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics. 2006; 5: 1760-71.1683757610.1074/mcp.R600004-MCP200
- Gonzales PA, Zhou H, Pisitkun T, Wang NS, Star RA, Knepper MA, et al. Isolation and purification of exosomes in urine. Methods Mol Biol. 2010; 641: 89-99.2040794310.1007/978-1-60761-711-2_6
- Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006; 70:1847-57.10.1038/sj.ki.500187417021608
- Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nature Methods. 2007; 4:207-14.1732784710.1038/nmeth1019
- Leelahavanichkul A, Yan Q, Hu X, Eisner C, Huang Y, Chen R, et al. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int. 2010; 78:1136-53.10.1038/ki.2010.287
- Holdt-Lehmann B, Lehmann A, Korten G, Nagel H, Nizze H, Schuff-Werner P. Diagnostic value of urinary alanine aminopeptidase and N-acetyl-β-D-glucosaminidase in comparison to a1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients. Clin Chim Acta. 2000; 297:93-102.10.1016/S0009-8981(00)00237-0
- Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic acids research. 2012; 40(Database issue):D1241-4.2198940610.1093/nar/gkr828
- Zager RA, Johnson AC, Frostad KB. Rapid renal alpha-1 antitrypsin gene induction in experimental and clinical acute kidney injury. PloS One. 2014; 9: e98380.10.1371/journal.pone.009838024848503
- Matsuda R, Kaneko N, Horikawa Y, Chiwaki F, Shinozaki M, Abe S, et al. Measurement of urinary annexin V by ELISA and its significance as a new urinary-marker of kidney disease. Clin Chim Acta. 2000; 298:29-43.10.1016/S0009-8981(00)00218-710876002
- Sasaki D, Yamada A, Umeno H, Kurihara H, Nakatsuji S, Fujihira S, et al. Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury. Biomarkers. 2011; 16:553-66.10.3109/1354750X.2011.613123
- Jung GS, Kim MK, Jung YA, Kim HS, Park IS, Min BH, et al. Clusterin attenuates the development of renal fibrosis. J Am Soc Nephrol. 2012; 23:73-85.2205205810.1681/ASN.2011010048
- Kida H, Abe T, Tomosugi N, Koshino Y, Yokoyama H, Hattori N. Prediction of the long-term outcome in acute interstitial nephritis. Clin Nephrol. 1984; 22: 55-60.6478672
- Leung KC, Tonelli M, James MT. Chronic kidney disease following acute kidney injury-risk and outcomes. Nat Rev Nephrol. 2013; 9:77-85.10.1038/nrneph.2012.28023247572
- Haase M, Mertens PR. Biomarkers: more than just markers! Nephrol Dial Transplant. 2015;30(1):33-8.10.1093/ndt/gfu08524755324
- Baserga R, Thatcher D, Marzi D. Cell proliferation in mouse kidney after a single injection of folic acid. Lab Invest. 1968; 19:92-6.5671357
- Ka SM, Tsai PY, Chao TK, Yang SM, Hung YJ, Chen JS, et al. Urine annexin A1 as an index for glomerular injury in patients. Dis Markers. 2014; 2014:854163.24591769
- Lee JW, Chou CL, Knepper MA. Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes. J Am Soc Nephrol. 2015; 26:2669-77.2581735510.1681/ASN.2014111067